Lab-on-a-Chip for Cardiovascular Physiology and Pathology

Lab-on-a-chip technologies have allowed researchers to acquire a flexible, yet relatively inexpensive testbed to study one of the leading causes of death worldwide, cardiovascular disease. Cardiovascular diseases, such as peripheral artery disease, arteriosclerosis, and aortic stenosis, for example,...

Full description

Bibliographic Details
Main Authors: Sean Beverung, Jingwen Wu, Robert Steward
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Micromachines
Subjects:
Online Access:https://www.mdpi.com/2072-666X/11/10/898
id doaj-a9f049ca44e34138b384f56f22f232b0
record_format Article
spelling doaj-a9f049ca44e34138b384f56f22f232b02020-11-25T01:38:56ZengMDPI AGMicromachines2072-666X2020-09-011189889810.3390/mi11100898Lab-on-a-Chip for Cardiovascular Physiology and PathologySean Beverung0Jingwen Wu1Robert Steward2Department of Mechanical and Aerospace Engineering, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL 32816, USADepartment of Mechanical and Aerospace Engineering, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL 32816, USADepartment of Mechanical and Aerospace Engineering, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL 32816, USALab-on-a-chip technologies have allowed researchers to acquire a flexible, yet relatively inexpensive testbed to study one of the leading causes of death worldwide, cardiovascular disease. Cardiovascular diseases, such as peripheral artery disease, arteriosclerosis, and aortic stenosis, for example, have all been studied by lab-on-a-chip technologies. These technologies allow for the integration of mammalian cells into functional structures that mimic vital organs with geometries comparable to those found in vivo. For this review, we focus on microdevices that have been developed to study cardiovascular physiology and pathology. With these technologies, researchers can better understand the electrical–biomechanical properties unique to cardiomyocytes and better stimulate and understand the influence of blood flow on the human vasculature. Such studies have helped increase our understanding of many cardiovascular diseases in general; as such, we present here a review of the current state of the field and potential for the future.https://www.mdpi.com/2072-666X/11/10/898lab-on-a-chipcardiovascular diseasemicrofluidicscell culture
collection DOAJ
language English
format Article
sources DOAJ
author Sean Beverung
Jingwen Wu
Robert Steward
spellingShingle Sean Beverung
Jingwen Wu
Robert Steward
Lab-on-a-Chip for Cardiovascular Physiology and Pathology
Micromachines
lab-on-a-chip
cardiovascular disease
microfluidics
cell culture
author_facet Sean Beverung
Jingwen Wu
Robert Steward
author_sort Sean Beverung
title Lab-on-a-Chip for Cardiovascular Physiology and Pathology
title_short Lab-on-a-Chip for Cardiovascular Physiology and Pathology
title_full Lab-on-a-Chip for Cardiovascular Physiology and Pathology
title_fullStr Lab-on-a-Chip for Cardiovascular Physiology and Pathology
title_full_unstemmed Lab-on-a-Chip for Cardiovascular Physiology and Pathology
title_sort lab-on-a-chip for cardiovascular physiology and pathology
publisher MDPI AG
series Micromachines
issn 2072-666X
publishDate 2020-09-01
description Lab-on-a-chip technologies have allowed researchers to acquire a flexible, yet relatively inexpensive testbed to study one of the leading causes of death worldwide, cardiovascular disease. Cardiovascular diseases, such as peripheral artery disease, arteriosclerosis, and aortic stenosis, for example, have all been studied by lab-on-a-chip technologies. These technologies allow for the integration of mammalian cells into functional structures that mimic vital organs with geometries comparable to those found in vivo. For this review, we focus on microdevices that have been developed to study cardiovascular physiology and pathology. With these technologies, researchers can better understand the electrical–biomechanical properties unique to cardiomyocytes and better stimulate and understand the influence of blood flow on the human vasculature. Such studies have helped increase our understanding of many cardiovascular diseases in general; as such, we present here a review of the current state of the field and potential for the future.
topic lab-on-a-chip
cardiovascular disease
microfluidics
cell culture
url https://www.mdpi.com/2072-666X/11/10/898
work_keys_str_mv AT seanbeverung labonachipforcardiovascularphysiologyandpathology
AT jingwenwu labonachipforcardiovascularphysiologyandpathology
AT robertsteward labonachipforcardiovascularphysiologyandpathology
_version_ 1725051275422203904